In April 2025, Amgen announced a study is to evaluate the safety, tolerability, and to determine the maximum tolerated dose ...

The U.S. Food and Drug Administration has approved Jobevne (bevacizumab-nwgd), a biosimilar to Avastin (bevacizumab) for ...

M-Strip, the self-sampling kit for cervical cancer (HPV) and STI screening, provides a non-invasive alternative to ...

Cervical cancer rates are on the rise among younger women, owing in part to a lack of screening and prevention.

Cervical cancer is a type of cancer that originates in the cervix—the lower part of the uterus that connects to the vagina.

Genmab has received approval from Japan's Ministry of Health, Labour and Welfare for its Tivdak to treat cervical cancer.

Genmab has announced that the European Commission (EC) has approved Tivdak (tisotumab vedotin) to treat recurrent or ...

Women in Papua New Guinea are being strongly encouraged to undergo early screening for cervical cancer to prevent the ...